# Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn

> **NCT04898114** · PHASE1,PHASE2 · RECRUITING · sponsor: **Sohag University** · enrollment: 40 (estimated)

## Conditions studied

- Persistent Pulmonary Hypertension of Newborn

## Interventions

- **DRUG:** Magnesium sulfate
- **DRUG:** Sildenafil Citrate
- **OTHER:** Isotonic saline

## Key facts

- **NCT ID:** NCT04898114
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-02
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-06-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04898114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04898114, "Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04898114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*